Targeting CD19+ B-Cells in IgG4-Related Disease: Clinical Evidence and Implications for Long-Term Management​ - Report from EULAR 2026

Dr. Emanuel Della Torre discusses the clinical evidence behind targeting CD19+ B-cells in IgG4-related disease in a post-congress interview following EULAR 2026. This recap focuses on the therapeutic impact of these strategies, underlying immunological mechanisms, and the long-term management implications for patients in clinical practice.Video: https://medicaldigest.org/scientific-contents/interview:targeting-cd19-b-cells-igg4-related-disease-clinical-evidence-and-implications-long-term-management